Naidu SS - Search Results

1

Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy.

Desai MY, Owens A, Geske JB, Wolski K, Naidu SS, Smedira NG, Cremer PC, Schaff H, McErlean E, Sewell C, Li W, Sterling L, Lampl K, Edelberg JM, Sehnert AJ, Nissen SE. Desai MY, et al. Among authors: naidu ss. J Am Coll Cardiol. 2022 Jul 12;80(2):95-108. doi: 10.1016/j.jacc.2022.04.048. J Am Coll Cardiol. 2022. PMID: 35798455 Free article. Clinical Trial.

2

Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention.

Naidu SS, Selzer F, Jacobs A, Faxon D, Marks DS, Johnston J, Detre K, Wilensky RL. Naidu SS, et al. Am J Cardiol. 2003 Nov 15;92(10):1160-4. doi: 10.1016/j.amjcard.2003.07.023. Am J Cardiol. 2003. PMID: 14609589

3

Alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in patients with prior coronary revascularization.

Khouzam RN, Naidu SS. Khouzam RN, et al. Among authors: naidu ss. J Invasive Cardiol. 2010 Dec;22(12):E220-4. J Invasive Cardiol. 2010. PMID: 21127375

4

Effect of gender and race on outcomes in dialysis-dependent patients undergoing percutaneous coronary intervention.

Parikh PB, Jeremias A, Naidu SS, Brener SJ, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L. Parikh PB, et al. Among authors: naidu ss. Am J Cardiol. 2011 May 1;107(9):1319-23. doi: 10.1016/j.amjcard.2010.12.042. Epub 2011 Feb 23. Am J Cardiol. 2011. PMID: 21349486

5

Survival and pacemaker risk after alcohol septal ablation: informing the choice of invasive therapy for hypertrophic cardiomyopathy.

Naidu SS. Naidu SS. Can J Cardiol. 2013 Nov;29(11):1369-70. doi: 10.1016/j.cjca.2013.05.003. Epub 2013 Jul 23. Can J Cardiol. 2013. PMID: 23890406 No abstract available.

6

Current status and future perspectives on alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

Khouzam RN, Naidu SS. Khouzam RN, et al. Among authors: naidu ss. Curr Cardiol Rep. 2014 May;16(5):478. doi: 10.1007/s11886-014-0478-3. Curr Cardiol Rep. 2014. PMID: 24633648 Review.

7

Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy: US Nationwide Inpatient Database, 2003-2011.

Kim LK, Swaminathan RV, Looser P, Minutello RM, Wong SC, Bergman G, Naidu SS, Gade CL, Charitakis K, Singh HS, Feldman DN. Kim LK, et al. Among authors: naidu ss. JAMA Cardiol. 2016 Jun 1;1(3):324-32. doi: 10.1001/jamacardio.2016.0252. JAMA Cardiol. 2016. PMID: 27438114

8

Pharmacological and non-pharmacological treatment of obstructive hypertrophic cardiomyopathy.

Hidalgo LF, Naidu SS, Aronow WS. Hidalgo LF, et al. Among authors: naidu ss. Expert Rev Cardiovasc Ther. 2018 Jan;16(1):21-26. doi: 10.1080/14779072.2018.1417038. Epub 2017 Dec 18. Expert Rev Cardiovasc Ther. 2018. PMID: 29231770

9

Performance Volume Thresholds for Alcohol Septal Ablation in Treating Hypertrophic Cardiomyopathy: Guidelines, Competency Statements, and Now Data.

Naidu SS. Naidu SS. Can J Cardiol. 2018 Jan;34(1):13-15. doi: 10.1016/j.cjca.2017.11.017. Epub 2017 Nov 29. Can J Cardiol. 2018. PMID: 29275876 No abstract available.

10

Interventional therapies for relief of obstruction in hypertrophic cardiomyopathy: discussion and proposed clinical algorithm.

Naidu SS, Jacobson J, Iwai S, Dutta T, Aronow WS, Poniros A, Malekan R, Spielvogel D, Panza JA. Naidu SS, et al. Hosp Pract (1995). 2018 Apr;46(2):58-63. doi: 10.1080/21548331.2018.1447738. Epub 2018 Mar 6. Hosp Pract (1995). 2018. PMID: 29490522 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page